Sovaprevir

DB12069InvestigationalSmall molecule

Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.

Chemical structure of Sovaprevir
Formula / weight
C43H53N5O8S · 799.98 g/mol (avg)
Code names
ACH-0141625

Resolves to

Compound
UNII2ND9V3MN6OCAS1001667-23-7ChEMBLCHEMBL2105750PubChem53362096
Structure
InChIKeyMHFMTUBUVQZIRE-WINRQGAFSA-NSMILESCOC1=CC2=NC(=CC(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](CC(=O)N3CCCCC3)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3CC3)=C2C=C1)C1=CC=CC=C1
Targets
P03366gag-pol

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Sovaprevir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In